Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000187663 | SCV000241260 | uncertain significance | not provided | 2015-01-02 | criteria provided, single submitter | clinical testing | p.Thr1229Ser (ACC>TCC): c.3685 A>T in exon 14 of the GRIN2A gene (NM_000833.3). The T1229S variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This substitution occurs at a position that is conserved in mammals; however, this position is not conserved in more distantly related species, and Serine has been seen at this position in evolution. Additionally, the T1229S variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In silico analysis predicts this variant likely does not alter the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in CHILD-EPI panel(s). |
Labcorp Genetics |
RCV002514007 | SCV003455338 | likely benign | Landau-Kleffner syndrome | 2023-01-19 | criteria provided, single submitter | clinical testing |